Carregando...
Obesity and Pediatric Drug Development
There is a shortage of dosing guidelines for use in obese children. Moreover, the impact of obesity on drug safety and clinical outcomes is poorly defined. The paucity of information needed for the safe and effective use of drugs in obese patients remains a problem, even after drug approval. To asse...
Na minha lista:
| Publicado no: | J Clin Pharmacol |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7335432/ https://ncbi.nlm.nih.gov/pubmed/29350758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.1054 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|